New and Nervous

Publication
Article
Oncology FellowsOctober 2013
Volume 5
Issue 3

It is OK to be jittery and unsure in a new role. It is OK to ask for a second opinion, and it is OK to admit that there are things one doesn’t know.

I was filled with excitement and enthusiasm as I looked forward to my first day as an attending physician in medical oncology. The training was finally over and the dream was finally realized. I was my own boss— that too with a fatter pay check. All I had to do was put my training to good use. How hard could that be!

My first new patient had a large mass hanging out of their liver with test results that revealed normal liver function, positive hepatitis B, normal alpha-fetoprotein, and a CT scan result that read “kindly correlate clinically.” As a result of a 3-year practice as a fellow, my instinct led me to my senior attending’s room, where I stopped at the threshold and realized that now I was an attending as well. “Should I go in and ask for help or try to sort it on my own?”

I began reading UpToDate and NCCN, but this time it was different. I was not supposed to read to impress my attending and follow his directions; I actually had to make a clinical decision on my own. For the first time, there was no second opinion. My decision was the final one—the one that may be good but also could be bad. And not to mention the note I’d sign could not be changed. (God, I wished so much for paper notes at this point.)

To add to the shakes, the primary team wanted my opinion on the patient’s possible diagnosis and need for an abdomen MRI quickly because they were planning discharge.

While I was thinking, a voice came from behind me.

“Doctor, shall we talk about the patients on the list?” Little did I realize that I had been sitting at the computer for over a half hour trying to ensure that I was not missing anything.

Now, there were over 20 patients on the inpatient list and my team of residents, students, and fellow gathered around waiting for me to discuss everything with them. Needless to say, I didn’t want to sound stupid in front of the team. So I decided to run through the old patient list first and then talk about this new patient.

Most patients on the list already had a plan in place and I was relieved that things were running at a good pace, until another dilemma arose. This time, I was faced with a young, 40-some-year-old patient with metastatic colon cancer and multiple large liver metastases. This patient had an excellent performance status but very deranged liver function with a bilirubin of over 15 with no ductal obstruction. He desired chemotherapy and the oncology team could not discuss this in detail with him until now. So, as the new attending on the team, it fell upon me to go and speak with him.

My fellow asked, “So what shall we do in this case?” It took me a moment to gather my wits to say, “Hmm let’s see…what do you think?” And I did emphasize the “YOU.”

There was a pause which offered me the chance to breathe for a few seconds. Finally, the team revealed they were not sure how to proceed. Since we were going to see patients after lunch, I dismissed them a little early and asked my fellow to read up and enlighten us on the chemotherapeutic options for colon cancer with severely deranged liver function.

For the first time in my life I thanked God that I had a stubby neck so that my racing pulse could not be seen by anyone. I rushed back to my room and began looking up information on the computer to enlighten myself. Lunch was forgotten, but at the end of the hour I somewhat had a plan for both of these patients. I would order a biopsy for the first patient and speak to the other patient about a dosereduced chemotherapy option, if he wanted it.

Rounds were going well and the discussion was more fruitful than I expected. My team had a good expression of tranquility about our progress and I felt that I would survive the day successfully. And as we expect a storm to follow a big quiet, just minutes before we called it a day, a call came from an ear, nose, and throat (ENT) resident in the operating room about a new consult.

This was a 30-some-year-old young man with a tongue mass and neck nodes, whose biopsy results revealed malignant melanoma. I take pride in the fact that during my training I saw a few cases of malignant melanoma and treated them, but this mucosal melanoma was a first.

The ENT resident was asking for chemotherapy options for him. I told them I needed to review the case before giving my opinion. The team looked at me for what looked like a nice essay they expected me to provide about mucosal melanomas. Instead, what followed was somewhat shabby by my standards but made my team light up with a smile…I asked them to go home since it was close to 5 o’clock and I explained that I would take this consult on my own.

The team happily departed and I was left once again thinking back to earlier that day...“How hard could this be!” I finally decided to conduct research again. However, I also decided to get a second opinion this time. I walked to my senior attending’s room. The door was open and I knocked gently, feeling a little embarrassed. She gave me a big smile and said “Finally…I was wondering when you would show up.”

I was surprised. She explained that throughout over 40 years of practicing oncology, watching 100+ fellows graduate, she learned everyone has some jitters in the beginning. She continued to explain that at some point everyone asks for an opinion to make sure they are doing things right. It comes with the great responsibility bestowed upon us to treat these patients who come to us with barely any hope. It is our job to support that hope and work toward turning that hope into reality. Being human, we don’t want to make mistakes with such important and deadly diagnoses.

I sat with her for over a half hour discussing the things I was planning to do with all of my new patients, and to see if I got the hang of it I even discussed the old patients on my list. It turned out that I did have the correct plan for all of the patients, I was just not 100% sure of myself.

This experience took place over 2 months ago and I have grown as an attending tremendously since then. What I learned from this experience is that it is OK to be jittery and unsure in a new role. It is OK to ask for a second opinion, and it is OK to admit that there are things one doesn’t know.

It happens to everyone, some more than others. It seems that it is perfectly normal to be “new and nervous!”

Shweta Gupta, MD, is an attending physician in the Department of Medicine’s Division of Hematology-Oncology at John H. Stroger Jr. Hospital of Cook County, Chicago, IL.

Related Videos
In this third episode of OncChats: Leveraging Immunotherapy in GI Malignancies, Toufic Kachaamy, MD, of City of Hope, Sunil Sharma, MD, of City of Hope, and Madappa Kundranda, MD, PhD, of Banner MD Anderson Cancer Center, discuss the potential benefits of utilizing immunotherapy approaches earlier on in the disease course.
A panel of 5 experts on renal cell carcinoma
A panel of 5 experts on renal cell carcinoma
In this second episode of OncChats: Leveraging Immunotherapy in GI Malignancies, Toufic Kachaamy, MD, of City of Hope, Sunil Sharma, MD, of City of Hope, and Madappa Kundranda, MD, PhD, of Banner MD Anderson Cancer Center, explain the challenges faced with preventing or detecting these cancers early and the understanding that is needed to develop effective early detection methods and move the needle forward.
Video 4 - "Predisposition for Patients Developing DTC: Age and Gender"
Video 3 "Determining Prognosis for Patients with Differentiated Thyroid Cancer"
In this first episode of OncChats: Leveraging Immunotherapy in GI Malignancies, Toufic Kachaamy, MD, of City of Hope, Sunil Sharma, MD, of City of Hope, and Madappa Kundranda, MD, PhD, of Banner MD Anderson Cancer Center, discuss the potential for early detection multiomic assays and the work that still needs to be done to encourage their widespread use.
Emmanuel Antonarakis, MD, associate director, Translational Research, Masonic Cancer Center, University of Minnesota, Clark Endowed Professor of Medicine, University of Minnesota Medical School
Gautam Jha, MD, medical director, M Health Fairview Masonic Cancer Clinic and the Advanced Treatment Center at the M Health Fairview Clinics and Surgery Center—Minneapolis, chair, cancer committee, M Health Fairview Ridges Hospital
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic